Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer.
Bae SJ, Kim JH, Ahn SG, Jeung HC, Sohn J, Kim GM, Kim MH, Kim SI, Park S, Park HS, Kim JY, Jeong J.
Bae SJ, et al. Among authors: kim jy, kim gm, kim si, kim mh, kim jh.
Front Oncol. 2021 Jun 4;11:689587. doi: 10.3389/fonc.2021.689587. eCollection 2021.
Front Oncol. 2021.
PMID: 34150658
Free PMC article.